Cargando…

HMOX1 is partly responsible for phenotypic and functional abnormalities in mesenchymal stem cells/stromal cells from placenta of preeclampsia (PE) patients

BACKGROUND: Preeclampsia is a common obstetric syndrome affecting women in their first pregnancy and characterized by hypertension and proteinuria, which appears after 20 weeks of gestation. It is characterized by high blood pressure and occasional damage to another organ system most often the liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Basmaeil, Yasser S., Algudiri, Dana, Alenzi, Reem, Al Subayyil, Abdullah, Alaiya, Ayodele, Khatlani, Tanvir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975087/
https://www.ncbi.nlm.nih.gov/pubmed/31964423
http://dx.doi.org/10.1186/s13287-020-1557-6
_version_ 1783490233688391680
author Basmaeil, Yasser S.
Algudiri, Dana
Alenzi, Reem
Al Subayyil, Abdullah
Alaiya, Ayodele
Khatlani, Tanvir
author_facet Basmaeil, Yasser S.
Algudiri, Dana
Alenzi, Reem
Al Subayyil, Abdullah
Alaiya, Ayodele
Khatlani, Tanvir
author_sort Basmaeil, Yasser S.
collection PubMed
description BACKGROUND: Preeclampsia is a common obstetric syndrome affecting women in their first pregnancy and characterized by hypertension and proteinuria, which appears after 20 weeks of gestation. It is characterized by high blood pressure and occasional damage to another organ system most often the liver and kidneys. Currently, the etiology and pathogenesis of this syndrome are not fully understood. Since mesenchymal stem cells/stromal cells (MSCs) are intimately associated with endothelial cells that line vessel walls in the decidua they may play some role in the pathogenesis of this syndrome. In this study, we have partly, unveiled the mechanism of preeclampsia pathogenesis at the stem cells level. METHODS: We have isolated and characterized MSCs from decidua basalis of preeclampsia placenta (PE-DBMSCs) and showed their decreased functionality in terms of proliferation, migration, adhesion and clone formation potential as compared to MSCs isolated from decidua region of normal placentae (DBMSCs). The cells were preconditioned with H(2)O(2) and the functional characteristics were evaluated. Differentially expressed genes were analyzed using mass spectrometry. Immunoblotting confirmed the expression of these proteins. RESULTS: Pre-conditioning with H(2)O(2) restored the functional outcome of PE-DBMSCs. Mass spectrometry (MS) analysis of differentially expressed proteins revealed HMOX1 as one of the major candidates missing in PE-DBMSCs. HMOX1 inhibition by tin protoporphyrin (SnPP) in normal DBMSCs resulted in a reduction in proliferation, migration, adhesion, and clone formation processes as compared to the untreated controls. mRNA and protein analyses of PE-DBMSCs preconditioned with H(2)O(2) at lower doses showed upregulation of HMOX1 expression. CONCLUSIONS: We hereby show for the first time that loss of function of stem cells/stromal cells isolated from the patients with preeclampsia may contribute towards the disease exacerbation. Our results suggest that HMOX1 may be partially responsible for the loss of functionality in PE-DBMSCs and contribute significantly towards the pathophysiology of preeclampsia. However, further investigation is required to decipher its exact role in the development and onset of the disorder.
format Online
Article
Text
id pubmed-6975087
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69750872020-01-28 HMOX1 is partly responsible for phenotypic and functional abnormalities in mesenchymal stem cells/stromal cells from placenta of preeclampsia (PE) patients Basmaeil, Yasser S. Algudiri, Dana Alenzi, Reem Al Subayyil, Abdullah Alaiya, Ayodele Khatlani, Tanvir Stem Cell Res Ther Research BACKGROUND: Preeclampsia is a common obstetric syndrome affecting women in their first pregnancy and characterized by hypertension and proteinuria, which appears after 20 weeks of gestation. It is characterized by high blood pressure and occasional damage to another organ system most often the liver and kidneys. Currently, the etiology and pathogenesis of this syndrome are not fully understood. Since mesenchymal stem cells/stromal cells (MSCs) are intimately associated with endothelial cells that line vessel walls in the decidua they may play some role in the pathogenesis of this syndrome. In this study, we have partly, unveiled the mechanism of preeclampsia pathogenesis at the stem cells level. METHODS: We have isolated and characterized MSCs from decidua basalis of preeclampsia placenta (PE-DBMSCs) and showed their decreased functionality in terms of proliferation, migration, adhesion and clone formation potential as compared to MSCs isolated from decidua region of normal placentae (DBMSCs). The cells were preconditioned with H(2)O(2) and the functional characteristics were evaluated. Differentially expressed genes were analyzed using mass spectrometry. Immunoblotting confirmed the expression of these proteins. RESULTS: Pre-conditioning with H(2)O(2) restored the functional outcome of PE-DBMSCs. Mass spectrometry (MS) analysis of differentially expressed proteins revealed HMOX1 as one of the major candidates missing in PE-DBMSCs. HMOX1 inhibition by tin protoporphyrin (SnPP) in normal DBMSCs resulted in a reduction in proliferation, migration, adhesion, and clone formation processes as compared to the untreated controls. mRNA and protein analyses of PE-DBMSCs preconditioned with H(2)O(2) at lower doses showed upregulation of HMOX1 expression. CONCLUSIONS: We hereby show for the first time that loss of function of stem cells/stromal cells isolated from the patients with preeclampsia may contribute towards the disease exacerbation. Our results suggest that HMOX1 may be partially responsible for the loss of functionality in PE-DBMSCs and contribute significantly towards the pathophysiology of preeclampsia. However, further investigation is required to decipher its exact role in the development and onset of the disorder. BioMed Central 2020-01-21 /pmc/articles/PMC6975087/ /pubmed/31964423 http://dx.doi.org/10.1186/s13287-020-1557-6 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Basmaeil, Yasser S.
Algudiri, Dana
Alenzi, Reem
Al Subayyil, Abdullah
Alaiya, Ayodele
Khatlani, Tanvir
HMOX1 is partly responsible for phenotypic and functional abnormalities in mesenchymal stem cells/stromal cells from placenta of preeclampsia (PE) patients
title HMOX1 is partly responsible for phenotypic and functional abnormalities in mesenchymal stem cells/stromal cells from placenta of preeclampsia (PE) patients
title_full HMOX1 is partly responsible for phenotypic and functional abnormalities in mesenchymal stem cells/stromal cells from placenta of preeclampsia (PE) patients
title_fullStr HMOX1 is partly responsible for phenotypic and functional abnormalities in mesenchymal stem cells/stromal cells from placenta of preeclampsia (PE) patients
title_full_unstemmed HMOX1 is partly responsible for phenotypic and functional abnormalities in mesenchymal stem cells/stromal cells from placenta of preeclampsia (PE) patients
title_short HMOX1 is partly responsible for phenotypic and functional abnormalities in mesenchymal stem cells/stromal cells from placenta of preeclampsia (PE) patients
title_sort hmox1 is partly responsible for phenotypic and functional abnormalities in mesenchymal stem cells/stromal cells from placenta of preeclampsia (pe) patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975087/
https://www.ncbi.nlm.nih.gov/pubmed/31964423
http://dx.doi.org/10.1186/s13287-020-1557-6
work_keys_str_mv AT basmaeilyassers hmox1ispartlyresponsibleforphenotypicandfunctionalabnormalitiesinmesenchymalstemcellsstromalcellsfromplacentaofpreeclampsiapepatients
AT algudiridana hmox1ispartlyresponsibleforphenotypicandfunctionalabnormalitiesinmesenchymalstemcellsstromalcellsfromplacentaofpreeclampsiapepatients
AT alenzireem hmox1ispartlyresponsibleforphenotypicandfunctionalabnormalitiesinmesenchymalstemcellsstromalcellsfromplacentaofpreeclampsiapepatients
AT alsubayyilabdullah hmox1ispartlyresponsibleforphenotypicandfunctionalabnormalitiesinmesenchymalstemcellsstromalcellsfromplacentaofpreeclampsiapepatients
AT alaiyaayodele hmox1ispartlyresponsibleforphenotypicandfunctionalabnormalitiesinmesenchymalstemcellsstromalcellsfromplacentaofpreeclampsiapepatients
AT khatlanitanvir hmox1ispartlyresponsibleforphenotypicandfunctionalabnormalitiesinmesenchymalstemcellsstromalcellsfromplacentaofpreeclampsiapepatients